Composition
- Active ingredients
- METHOTREXATE 27.5MG/0.55ML (27.5MG/0.55ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- METHOTREXATE 27.5MG/0.55ML (27.5MG/0.55ML) · SolutionThis page
- METHOTREXATE 22.5MG/0.45ML (22.5MG/0.45ML) · SolutionNDA205776-007 · Prescription
- METHOTREXATE 17.5MG/0.35ML (17.5MG/0.35ML) · SolutionNDA205776-005 · Prescription
- METHOTREXATE 12.5MG/0.25ML (12.5MG/0.25ML) · SolutionNDA205776-003 · Prescription
- METHOTREXATE 7.5MG/0.15ML (7.5MG/0.15ML) · SolutionNDA205776-001 · Prescription
- METHOTREXATE 25MG/0.5ML (25MG/0.5ML) · SolutionNDA205776-008 · Prescription
- METHOTREXATE 20MG/0.4ML (20MG/0.4ML) · SolutionNDA205776-006 · Prescription
- METHOTREXATE 15MG/0.30ML (15MG/0.30ML) · SolutionNDA205776-004 · Prescription
- METHOTREXATE 30MG/0.6ML (30MG/0.6ML) · SolutionNDA205776-010 · Prescription
- METHOTREXATE 10MG/0.20ML (10MG/0.20ML) · SolutionNDA205776-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA205776.
At a glance
- Brand name
- Rasuvo
- Active substance
- methotrexate
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Medexus
- Status
- Discontinued
- FDA approval
- 10 Jul 2014
- Application
- NDA205776-009